People with diabetes often experience foot complications. Diabetic neuropathy is one of the complications that arises due to consistently elevated blood sugar levels. It is the damage to nerves that ...

Diabetic shock, or severe hypoglycaemia, occurs when blood sugar levels plummet dangerously low, posing significant health risks. Recognizing early warning signs like trembling, sweating, and ...

Strong evidence suggests that following the diet, cutting calories and exercising lowers the chances of developing diabetes for those with metabolic risk factors. By Nina Agrawal Powerful new evidence ...

Last patient last visit (LPLV) was reached for the 127 adult and elderly patients enrolled into the 12-week placebo-controlled trial with nispomeben (NRD.E1) Topline results are expected in November ...

“Our study shows that modest, sustained changes in diet and lifestyle could prevent millions of cases of type 2 diabetes worldwide,” said coauthor Dr. Frank Hu, the Fredrick J. Stare Professor of ...

For people suffering from the burning, tingling and shooting pain of neuropathy, current treatments are limited and often fail to bring lasting relief. But help may be on the horizon. Northeastern ...

Nutritionist Suman Agarwal highlights the health risks associated with common Indian foods like papad, bhujia, jalebi, samosa, and supari. These seemingly harmless snacks, often high in sodium, sugar, ...

Eli Lilly says its experimental GLP-1 pill helped overweight adults with Type 2 diabetes shed 10.5% of body weight in a late-stage trial, after recent data from another study of the drug in patients ...

After Eli Lilly’s phase 3 data drop for its oral GLP-1 asset orforglipron earlier this month, the Indianapolis drugmaker has unveiled the second half of the data package that will support the med’s ...

A GLP-1 drug in pill form — no needles required — helped people with obesity and Type 2 diabetes lose 10% of their body weight and lower their blood sugar levels, pharmaceutical giant Eli Lilly ...

There is a simple discount patient access scheme for idebenone. NHS organisations can get details on the Commercial Access and Pricing (CAP) Portal. Non-NHS organisations can contact ...